Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Holter ECG Market Outlook

The global Holter ECG market size was valued at USD 543.3 million in 2023, driven by the increasing prevalence of cardiovascular diseases across the globe. The market size is anticipated to grow at a CAGR of 7.6% during the forecast period of 2024-2032 to achieve a value of USD 1053.9 million by 2032.

holter ecg market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Holter ECG Market Overview

Holter ECG is an ambulatory electrocardiography device that records the heart rhythms of a patient for at least 24 hours. It is portable, consists of adhesive electrodes that are attached to the chest, and offers an accurate diagnosis of any cardiac condition over several days.

The rising demand for 12-lead Holter ECG is driving the market growth of Holter ECG. The inclination towards 12-lead Holter ECG over traditional Holter ECG displaying two or three leads is due to the offering of vector information and its efficiency in diagnosing arrhythmias and localisation of myocardial ischemia, which is bolstering the market development of Holter ECG. In addition, they play a critical role in evaluating the effect of drugs or interventional therapeutic procedures in patients with heart failure and permanent atrial fibrillation, which is leading Holter ECG market growth.

Also, they offer information for risk stratification with the automatic analysis of parameters in 12-lead Holter ECG and are very accurate in the diagnosis of supraventricular tachycardia (SVT), ventricular tachycardia (VT), atrial flutter, atrial fibrillation, and monomorphic or Polymorphic VTs, thus invigorating the market growth. The efforts taken by market players in developing 12-lead Holter ECG with active electrodes, battery life, and that are compatible with T-shirts are likely to aid the market for Holter ECG over the forecast period.

The increasing prevalence of cardiovascular diseases and the mortality rates associated with them are contributing to the steady market growth of Holter ECG. The importance of Holter ECG in assisting doctors in diagnosing and providing accurate treatment for critical cardiac conditions by continuously monitoring the heart rhythms of a patient is providing impetus to market development. In addition, the rising preference for Holter ECG due to its portability and non-interference with the routine activities of the patients is contributing the Holter ECG market share. The reduced availability of medical staff is also contributing to the market expansion of personal healthcare systems such as Holter ECG.

Moreover, the Holter ECG plays a critical role in eliminating the need for extended stays at hospitals, offers better patient recovery in home environments, and is also cost-effective. The government initiatives in developing such long-term monitoring solutions for accurate diagnosis and reducing cardiovascular diseases among the population are propelling the market for Holter ECG. Further, the investments made in the development of Holter ECGs with extended recording and episode detection are expected to aid the Holter ECG market growth over the forecast period.

Prominent FDA Approvals

In May 2023, Abbott’s Assert-IQ™ insertable cardiac monitor (ICM) received U.S. Food and Drug Administration (FDA) clearance, providing physicians with a new option for diagnostic evaluation and long-term monitoring of people experiencing irregular heartbeats. This clearance builds on Abbott's portfolio of connected health devices that can better help doctors manage and treat their patients remotely.

ICM's small devices contain sensors that are inserted just under the skin of the chest. These devices are designed to monitor a person's heart constantly and in real time. Using Bluetooth® technology, Abbott's Assert-IQ ICM is designed to remain connected to a transmitter, usually the person's cell phone where it checks heart rhythms every 20 seconds, transmitting results in real-time to the clinic's portal.

The market for Holter ECG is expected to grow significantly with the development of a low-cost Holter monitor that is wireless and equipped with AI-assisted diagnostics. This innovative device promises quick and accurate cardiac screening, which plays a significant role in underprivileged areas where cardiovascular death rates are rising. By providing accessible and innovative healthcare solutions, this device has the potential to boost global Holter ECG market growth.

Additionally, in Jan 2024, iRhythm Technologies received European approval for its latest Zio wearable cardiac monitor, designed to detect irregular heartbeats such as atrial fibrillation. The new model is made compact, thinner, and lighter compared to the previous Zio XT ECG-recording patch. According to iRhythm, cases of arrhythmia and stroke have been on the rise in Europe, creating a sense of urgency for improved detection. The CE mark’s green light covers both the 14-day Zio wearable monitor and its artificial intelligence-powered ECG analysis software, dubbed ZEUS.

The approval for the Zio wearable cardiac monitor in Europe which is also addressing the increasing cases of arrhythmia and stroke may result in Holter ECG market growth. The smaller design and advanced AI analysis offer improved detection, meeting the rising demand for enhanced cardiac monitoring solutions.

Research Activities Poised to Bring Innovation in the Market

October 2023, research conducted by Azlaan Ranjha, Laiba Jabbar, Osaid Ahmed focused on creating a wireless, transportable Holter monitor with a specific emphasis on improving cardiac disease diagnosis accuracy. The main goal was to develop a low-cost cardiac screening system tailored for underprivileged areas to address the increasing rates of cardiovascular death. The study demonstrated a deep neural network's superior diagnostic performance, surpassing cardiologist-level ECG analysis with over 88% accuracy. This breakthrough integrates wireless data transfer with cost-effective AI-assisted diagnostics, providing a swift and accurate cardiac screening option.

The development of a wireless, low-cost Holter monitor with advanced AI-assisted diagnostics, achieving over 88% accuracy in cardiac anomaly identification may significantly boost the global Holter ECG market research by providing a more accessible and efficient cardiac screening solution, especially in underprivileged areas.

holter ecg market by segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Holter ECG Market Segmentations

Market Breakup by Lead Type

  • Patch Type Single Monitor
  • 3 Lead Holter Monitors
  • 6 Lead Holter Monitors
  • 12 Lead Holter Monitors
  • Others

Market Breakup by Application

  • Diagnostic
  • Monitoring

Market Breakup by Product

  • Wired Holter ECG Monitors
  • Wireless Holter ECG Monitors
  • Software

Market Breakup by End User

  • Hospitals and Clinics
  • Ambulatory Facilities
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

holter ecg market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Global Holter ECG Market Regional Analysis

North America is currently dominating the market due to factors such as the growing incidence of cardiovascular diseases, rising geriatric population, surging demand for remote monitoring, and the proliferation of advanced monitoring devices. The market is further propelled by technological advancements, preference shift towards ambulatory ECG monitoring, the introduction of next-generation wireless monitoring devices, and strategic technological collaborations among manufacturers.

For instance, in May 2023, BIOTRONIK received U.S. Food and Drug Administration (FDA) approval for the BIOMONITOR IV implantable cardiac monitor (ICM), its latest innovation to improve the standard of care in cardiac monitoring. The device, featuring BIOTRONIK’s advanced, AI-powered* SmartECG algorithm, will make its debut at the Heart Rhythm Society Congress 2023 in New Orleans.

BIOMONITOR IV, with SmartECG technology, significantly reduces false atrial fibrillation alerts by 86%, easing the burden on clinicians. It ensures 98% accuracy in detecting true episodes, helping timely and accurate diagnosis. This advancement is likely to boost the Holter ECG market technologies. In addition to the SmartECG technology, BIOMONITOR IV is the first ICM to discriminate between premature atrial contractions (PACs) and premature ventricular contractions (PVCs) marking a significant step forward in the domain of remote cardiac monitoring by providing healthcare professionals with reliable PAC and PVC trends for risk stratification and diagnosis.

The FDA approval for BIOMONITOR IV with advanced SmartECG technology significantly reduces false positive atrial fibrillation detections by 86%, aiding clinicians in accurate diagnoses. Its ability to differentiate between PACs and PVCs, along with enhanced remote monitoring features, is a major factor poised to positively influence the global Holter ECG market growth.

Global Holter ECG Market: Competitor Landscape

In May 2023, On May 2023, Philips revealed AI research predicting life-threatening ventricular arrhythmias at a Heart Rhythm Society congress. Using a deep neural network and 115,505 ECG recordings, the AI accurately forecasted sustained ventricular tachycardia over two weeks, showcasing potential in cardiac monitoring.

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • GE Healthcare
  • Philips Healthcare
  • Medtronic plc
  • Schiller AG
  • Welch Allyn (now part of Hillrom)
  • BioTelemetry, Inc. (now part of Philips)
  • Spacelabs Healthcare (a subsidiary of OSI Systems, Inc.)
  • Nihon Kohden Corporation
  • ScottCare Corporation (a subsidiary of Biotronik)
  • iRhythm Technologies, Inc.
  • Cardionet (a subsidiary of BioTelemetry, Inc.)
  • Applied Cardiac Systems, Inc.
  • Compumed Inc.
  • Scott Medical Products (a subsidiary of Cardinal Health)
  • Midmark Corporation

Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Lead Type
  • Application
  • Product
  • End User
  • Region
Breakup by Lead Type
  • Patch Type Single Monitor
  • 3 Lead Holter Monitors
  • 6 Lead Holter Monitors
  • 12 Lead Holter Monitors
  • Others
Breakup by Application
  • Diagnostic
  • Monitoring
Breakup by Product
  • Wired Holter ECG Monitors
  • Wireless Holter ECG Monitors
  • Software
Breakup by End User
  • Hospitals and Clinics
  • Ambulatory Facilities
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • GE Healthcare
  • Philips Healthcare
  • Medtronic plc
  • Schiller AG
  • Welch Allyn (now part of Hillrom)
  • BioTelemetry, Inc. (now part of Philips)
  • Spacelabs Healthcare (a subsidiary of OSI Systems, Inc.)
  • Nihon Kohden Corporation
  • ScottCare Corporation (a subsidiary of Biotronik)
  • iRhythm Technologies, Inc.
  • Cardionet (a subsidiary of BioTelemetry, Inc.)
  • Applied Cardiac Systems, Inc.
  • Compumed Inc.
  • Scott Medical Products (a subsidiary of Cardinal Health)
  • Midmark Corporation

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market attained a value of about USD 543.3 million in 2023, driven by the rising prevalence of CVD.

The market is anticipated to grow at a CAGR of 7.6% during the forecast period of 2024-2032 and is likely to reach a market value of USD 1053.9 million by 2032.

Factors including the rising demand for 12-lead Holter ECG, increasing prevalence of cardiovascular diseases, rising preference for Holter ECG due to its portability and non-interference with routine activities, FDA approvals, research activities, and product launches are major factors aiding the market demand.

Market players launching new technologies such as Abbott’s Assert-IQ™ insertable cardiac monitor (ICM) is a major trend influencing market growth.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.

Types include patch type single monitors, 3 lead Holter monitors, 6 lead Holter monitors, and 12 lead Holter monitors, among others.

Holter ECG can be used in diagnostics and monitoring.

Types of products available in the market include wired Holter ECG monitors, wireless Holter ECG monitors, and software.

End users in the market are Holter ECG clinic and ambulatory facilities, among others.

Key players involved in the market are GE Healthcare, Philips Healthcare, Medtronic plc, Schiller AG, Welch Allyn (now part of Hillrom), BioTelemetry, Inc. (now part of Philips), Spacelabs Healthcare (a subsidiary of OSI Systems, Inc.), Nihon Kohden Corporation, ScottCare Corporation (a subsidiary of Biotronik), iRhythm Technologies, Inc., Cardionet (a subsidiary of BioTelemetry, Inc.), Applied Cardiac Systems, Inc., Compumed Inc., Scott Medical Products (a subsidiary of Cardinal Health), and Midmark Corporation.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124